LivaNova PLC (NASDAQ:LIVN) Stock Has Average Target Price of $87.75 According to Analysts

Key Points

• Analysts have a “Moderate Buy” consensus on LivaNova, with six buy ratings, one strong-buy rating, and four holds. The average 12-month price target is $87.75, above the reported share price of $75.91.
• LivaNova’s latest quarterly results exceeded expectations: earnings per share came in at $1.26 versus the $1.09 consensus estimate, while revenue rose 10.8% year over year to $390.59 million.
• Insiders sold shares worth approximately $591,839 over the past three months, while institutional investors own a substantial 97.64% of the company.

Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $87.75.

A number of brokerages have recently commented on LIVN. Barclays raised LivaNova to a "strong-buy" rating in a research note on Wednesday. Weiss Ratings upgraded shares of LivaNova from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 18th. Mizuho lifted their target price on shares of LivaNova from $90.00 to $95.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 15th. Piper Sandler reissued an "overweight" rating and set a $90.00 target price (up from $87.00) on shares of LivaNova in a report on Wednesday, September 2nd. Finally, Zacks Research cut shares of LivaNova from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 19th.

Insider Buying and Selling at LivaNova

In related news, Director Brooke Story sold 2,300 shares of the stock in a transaction on Friday, September 4th. The stock was sold at an average price of $81.42, for a total value of $187,266.00. Following the completion of the sale, the director directly owned 7,488 shares in the company, valued at $609,672.96. This represents a 23.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Francesco Bianchi sold 3,500 shares of the firm's stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total value of $273,035.00. Following the transaction, the director directly owned 4,434 shares of the company's stock, valued at approximately $345,896.34. This represents a 44.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 7,450 shares of company stock worth $591,839. 0.35% of the stock is currently owned by insiders.

Institutional Investors Weigh In On LivaNova

Institutional investors and hedge funds have recently made changes to their positions in the stock. Allworth Financial LP increased its position in shares of LivaNova by 93.5% during the second quarter. Allworth Financial LP now owns 298 shares of the company's stock worth $25,000 after buying an additional 144 shares during the period. Farther Finance Advisors LLC raised its stake in LivaNova by 59.7% during the third quarter. Farther Finance Advisors LLC now owns 452 shares of the company's stock worth $35,000 after buying an additional 169 shares during the last quarter. State of Michigan Retirement System lifted its holdings in LivaNova by 1.5% in the first quarter. State of Michigan Retirement System now owns 13,111 shares of the company's stock valued at $833,000 after buying an additional 200 shares during the period. GAMMA Investing LLC lifted its holdings in LivaNova by 12.5% in the third quarter. GAMMA Investing LLC now owns 2,068 shares of the company's stock valued at $158,000 after buying an additional 230 shares during the period. Finally, Oregon Public Employees Retirement Fund boosted its position in LivaNova by 2.7% during the first quarter. Oregon Public Employees Retirement Fund now owns 11,250 shares of the company's stock valued at $715,000 after acquiring an additional 300 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Trading Down 0.0%

Shares of LIVN opened at $75.91 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.45. LivaNova has a 52-week low of $48.82 and a 52-week high of $85.76. The firm has a market cap of $4.18 billion, a price-to-earnings ratio of 22.46 and a beta of 0.87. The business's fifty day moving average is $78.86 and its 200-day moving average is $75.00.

LivaNova (NASDAQ:LIVN - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.17. LivaNova had a return on equity of 16.35% and a net margin of 12.82%.The business had revenue of $390.59 million for the quarter, compared to analyst estimates of $380.50 million. During the same period last year, the firm posted $1.05 earnings per share. LivaNova's revenue was up 10.8% compared to the same quarter last year. Equities analysts anticipate that LivaNova will post 3.78 EPS for the current fiscal year.

About LivaNova

LivaNova PLC NASDAQ: LIVN is a medical device company that develops and markets technologies for the treatment of cardiovascular and neurological conditions. The company's principal businesses are organized around its Cardiopulmonary and Neuromodulation segments.

Its cardiopulmonary portfolio includes heart-lung machines, oxygenators, perfusion systems and other equipment used during cardiopulmonary bypass procedures, as well as technologies designed to support cardiac surgery and related clinical applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.